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the knee joints of CFA-induced arthritic
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Abstract
Background: The effect of cold temperature on arthritis symptoms is unclear. The aim of this study was to
investigate how environmental cold affects pain and blood flow in mono-arthritic mice, and examine a role for
transient receptor potential ankyrin 1 (TRPA1), a ligand-gated cation channel that can act as a cold sensor.
Methods: Mono-arthritis was induced by unilateral intra-articular injection of complete Freund’s adjuvant (CFA) in
CD1 mice, and in mice either lacking TRPA1 (TRPA1 KO) or respective wildtypes (WT). Two weeks later, nociception
and joint blood flow were measured following exposure to 10 °C (1 h) or room temperature (RT). Primary
mechanical hyperalgesia in the knee was measured by pressure application apparatus; secondary mechanical
hyperalgesia by automated von Frey system; thermal hyperalgesia by Hargreaves technique, and weight bearing by
the incapacitance test. Joint blood flow was recorded by full-field laser perfusion imager (FLPI) and using clearance
of 99mTechnetium. Blood flow was assessed after pretreatment with antagonists of either TRPA1 (HC-030031),
substance P neurokinin 1 (NK1) receptors (SR140333) or calcitonin gene-related peptide (CGRP) (CGRP8–37). TRPA1,
TAC-1 and CGRP mRNA levels were examined in dorsal root ganglia, synovial membrane and patellar cartilage
samples.
Results: Cold exposure caused bilateral primary mechanical hyperalgesia 2 weeks after CFA injection, in a TRPA1-
dependent manner. In animals maintained at RT, clearance techniques and FLPI showed that CFA-treated joints
exhibited lower blood flow than saline-treated joints. In cold-exposed animals, this reduction in blood flow
disappears, and increased blood flow in the CFA-treated joint is observed using FLPI. Cold-induced increased blood
flow in CFA-treated joints was blocked by HC-030031 and not observed in TRPA1 KOs. Cold exposure increased
TRPA1 mRNA levels in patellar cartilage, whilst reducing it in synovial membranes from CFA-treated joints.
Conclusions: We provide evidence that environmental cold exposure enhances pain and increases blood flow in a
mono-arthritis model. These changes are dependent on TRPA1. Thus, TRPA1 may act locally within the joint to
influence blood flow via sensory nerves, in addition to its established nociceptive actions.
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Background
Anecdotal evidence of a link between weather changes
and arthritis symptoms has abounded for centuries; sev-
eral studies have shown that the vast majority of arthritic
patients believe their condition to be weather-sensitive
[1, 2]. In rheumatoid arthritis, low temperatures in par-
ticular are thought to be associated with exacerbated
pain [2–4], though this association is contested [5]. One
particular issue in trying to delineate this phenomenon
is that it is often difficult to distinguish the effect of cold
independently from other weather variables, such as
pressure and humidity, or indeed the psychological effect
of inclement weather [5].
To date, there have been few studies to assess the
effect of cold on pain in arthritis. Rats with complete
Freund’s adjuvant (CFA)-induced arthritis have an ex-
aggerated hyperalgesic response and sensitized pri-
mary afferents after exposure to cold [6, 7], though
the underlying mechanisms are not fully understood.
One potential mediator is the transient receptor po-
tential ankyrin 1 (TRPA1) channel, shown to be es-
sential for acute cold hypersensitivity in hindpaw
inflammatory models [8–10]. TRPA1 is a ligand-gated
non-selective Ca2+ transducer expressed on neuronal
and non-neuronal cells [11, 12]. The channel is acti-
vated by temperatures ranging from 10 °C to 17 °C
[12, 13], though its role as a cold sensor in vivo is
controversial [14]. Conversely, TRPA1 has well-
established roles in inflammatory pain, and can be ac-
tivated by a wide range of endogenous reactive com-
pounds generated by oxidative stress, including
hydrogen peroxide [15]. We have previously demon-
strated that TRPA1 mediates tumour necrosis factor
alpha (TNF-α)-induced inflammatory pain by modu-
lating mechanical hyperalgesia via both the central
and peripheral nervous systems [16]. In addition,
TRPA1 plays an important role in noxious mechano-
sensation in normal, inflamed and osteoarthritic
models [17], and we have observed a sustained mech-
anical hyperalgesia in wild-type (WT) but not TRPA1
knockout (KO) mice with CFA-induced mono-
arthritis [16].
As well as sensing noxious stimuli, leading to the per-
ception of pain, another key function of sensory nerves
is their ability to release potent vasoactive neuropep-
tides, including substance P (SP) and calcitonin gene-
related peptide (CGRP), into the surrounding tissue,
leading to neurogenic inflammation [18]. We have
shown that TRPA1 activation leads to neuropeptide-
dependent vasodilatation [19]. Arthritic patients exhibit
alterations in the function of their microvasculature [20],
and decreased blood flow in the synovial joint has been
observed in rat models of CFA-induced arthritis [21–
23]. While the link between environmental cold and
blood flow in arthritic joints is not clear at present,
rheumatoid arthritis has been associated with Raynaud’s
syndrome, which is defined by episodic ischemia of the
extremities in response to cold, and defective blood flow
regulation [24].
Here, we have established a model of 1 h exposure to
10 °C environmental cold, and used it to investigate the
changes in pain sensitivity and blood flow in the knee
joint of CFA-induced mono-arthritic mice. Using both
TRPA1 antagonists and KO mice, we have investigated
whether TRPA1 is linked to these changes. Our results
reveal that TRPA1 influences vascular responsiveness
and pain sensitivity following cold exposure.
Methods
Animals
TRPA1 transgenic mice, as described by [25] were pro-
duced using heterozygous breeding pairs (on a mixed
genetic background: C57BL/6 J and B6129PF2/J strains)
to give litters of mixed genotypes, including TRPA1 KO
animals (lacking functional TRPA1), WT control animals
(with functional TRPA1), and heterozygous animals.
Age-matched male KO and WT mice (25–35 g, 10–12
weeks of age) were used for experiments. For antagonist
studies, male CD1 mice (25–35 g, 10–12 weeks of age;
Charles River, Margate, UK) were also used. Mice were
maintained in a climatically controlled environment
(19–21 °C), with access to food and water ad libitum. All
experiments were carried out in accordance with the
1986 UK Home Office Animals (Scientific Procedures)
Act, with ethical approval from King’s College London.
All recovery procedures were performed using 2 % iso-
flurane anesthesia; 30-gauge needles were used for intra-
articular (i.art.) injections (BD Micro-Fine insulin syrin-
ges, 0.3 ml; BD Medical, Oxford, UK).
CFA-induced knee joint inflammation and environmental
cold exposure
Mono-arthritis was induced in mice by i.art. injections
of CFA (10 μg/10 μl) into the ipsilateral knee joint, and
10 μl saline (0.9 % sodium chloride, pyrogen-free; Baxter
Healthcare, Newbury, UK) into the contralateral joint; as
in [16]. Inflammation was allowed to develop for
2 weeks, at which point hyperalgesia and knee joint
blood flow were assessed. Prior to measurements, ani-
mals were maintained at either environmental room
temperature (RT; 22–23 °C) or exposed to cold (10 °C)
for 1 h. For environmental cold exposure, mice were in-
dividually caged with minimal bedding in an enclosed
cooled environment with access to food and water. RT
humidity was 40.3 ± 1.3 % and cold humidity was 41.7 ±
2.3 %. RT pressure was 1013 ± 1.2 mb and cold pressure
was 1013 ± 5.6 mb.
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Nociceptive and weight-bearing experiments
Nociceptive experiments were carried out on 26 CD1, 6
TRPA1 WT and 6 TRPA1 KO mice. For the primary
mechanical hyperalgesia measurements, a pressure
application measurement device (Ugo Basile, Comerio,
Italy; [26]) was used. Mice were scruffed and a digital
touch stimulator was placed on the side of the knee
joint. An increasing force (at a rate of 30 g/s, as opti-
mized in [26]) was applied to the knee joint with a cut-
off of 550 g, and knee joint withdrawal and/or
vocalization were used as indicators of nociceptive
threshold. Mice were trained once before baseline mea-
surements to prevent freezing during the scruffing pro-
cedure. Measurements were taken twice for each joint
over a period of 2 days to reduce stress. Results are
expressed as knee withdrawal threshold (g). For the
measurement of secondary mechanical hyperalgesia, a
dynamic plantar aesthesiometer (Ugo Basile) was used,
as in [16]. Mice were placed in transparent cages with a
wire mesh floor and acclimatized for 30 min before
readings started. Measurements were obtained with a
straight metal filament (0.5-mm diameter), which exerts
an increasing upward force (1 g every 0.1 s) when touch-
ing the plantar surface of the hind paw. Measurements
were stopped when the paw was withdrawn, and results
are expressed as mean paw withdrawal threshold (g)
over three experiments. The cut-off force was set at
50 g. Secondary thermal hyperalgesia thresholds were
evaluated using the Hargreaves technique (Ugo Basile; as
described previously [27]). Mice were placed in behav-
ioural boxes on a glass platform and acclimatized for
30 min. An automatic heat source (50 W, 10 V) was di-
rected at the mouse footpad until paw withdrawal, foot
drumming, licking or any other aversive action was ob-
served. A cut-off time of 22 s was used to avoid tissue
damage. Measurements were taken in triplicate and
mean paw withdrawal latency (s) was calculated.
Weight bearing was determined using an incapaci-
tance tester (Linton Instrumentation, Diss, UK; [28]).
Measurements were taken when mice were positioned
with their head and front paws resting on the sloping
side of the plastic box and hind paws were centred
on each force plate with no overlap. Three measure-
ments were taken, and results are expressed as per-
centage weight on ipsilateral limb. A result of 50 %
indicates equal distribution, while values <50 % indi-
cate a preference for weight bearing on the contralat-
eral limb.
All pain behaviour measurements were taken before
(baseline) and 2 weeks after mono-arthritis induction.
Immediately before the 2-week measurements, mice
were either maintained at RT or exposed to cold (10 °C)
for 1 h. Experiments were performed in a blinded
fashion where possible.
Knee joint blood flow measurements
Knee joint blood flow was assessed by full-field laser per-
fusion imager (FLPI; Moor Instruments, Axminster, UK)
in 6 WT, 7 TRPA1 KO and 79 CD1 mice. Briefly, 2 weeks
after CFA injection, animals were either maintained at
RT or exposed to cold (10 °C) for 1 h. Immediately
thereafter, mice were fully anaesthetized with a mixture
of ketamine (75 mg/kg) and medetomidine (1 mg/kg).
Naïve RT-exposed (n = 5) and naïve cold-exposed (n = 5)
CD1 mice were used as controls. Skin overlying the knee
joints was removed and the patellar ligament carefully
dissected to expose the synovial membrane. Blood flow
was recorded in a defined region of interest encompass-
ing the synovial membrane for 30 min. The imager uses
speckle contrast imaging to detect changes in blood flow
[29, 30]. An arbitrary flux value is produced, which gives
the average flow over the defined region of interest. In-
creases in flux values correspond to increases in blood
flow in the joint. Results are expressed as mean flux
value for the 30-min recording period.
99mTc clearance technique to measure changes in blood
flow
Knee joint blood flow was also assessed using a clear-
ance technique [30] in 24 CD1 mice. Naïve RT-exposed
(n = 5) and naïve cold-exposed CD1 (n = 5) mice were
used as controls. Two weeks after CFA injection, ani-
mals were either maintained at RT or exposed to cold
(10 °C) for 1 h, and were then immediately fully anaes-
thetized with a mixture of ketamine (75 mg/kg) and
medetomidine (1 mg/kg). A 20 μl injection of radioactive
99mTechnetium (99mTc, diluted in saline, approximately
5 kBq per site; Nuclear Medicine, Guy’s Hospital,
London) was administered into both knee joints. Imme-
diately after each injection, the radioactivity in the joint
was determined using a collimated gamma probe
(Europrobe, Bright Technologies, Sheffield, UK). The
head of the probe was held against the joint region and
counts/min detected in the joint were recorded. Read-
ings were repeated every minute for each joint over a
period of 10 min. An equal amount of saline + 99mTc
was used as a measurement of total radioactivity, and
was measured before and after each experiment to con-
firm the stability of the radioisotope.
Real-time PCR analysis
Real-time quantitative PCR [31] was used to assess
the effect of inflammation and cold exposure on
TRPA1 mRNA expression. Both the contralateral (sa-
line-injected) and ipsilateral (CFA-injected) synovial
membrane, patellar cartilage and lumbar L2-L5 dorsal
root ganglia (DRG) samples were isolated from arth-
ritic mice exposed to RT or cold, for quantification of
TRPA1, TAC-1 (the gene encoding SP) and αCGRP
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mRNA levels. Samples were collected after blood flow
recording, and stored in RNAlater® until RNA extrac-
tion was performed. DNA-free total RNA was ex-
tracted from samples using the RNeasy Microarray kit
(Qiagen, Manchester, UK), and 0.5 μg of total DRG
RNA, or 0.15 μg of total synovial membrane and pa-
tellar cartilage RNA was reverse transcribed to cDNA
using the High Capacity RNA-to-cDNA kit with
RNAse inhibitor (Applied Biosystems, Warrington,
UK) according to the manufacturer’s instructions.
Real-time PCR was performed on a Corbett Rotor-
gene (hold: 10 min at 95 °C; cycling: 45 cycles of
10 s at 95 °C, 15 s at 57 °C and 5 s at 72 °C; melt:
68–90 °C), using the SensiMix™ SYBR No-ROX Kit
(Bioline, London, UK). The following primers were
obtained from Sigma-Aldrich, Gillingham, UK:
TRPA1 [forward: 5′-AGGTGATTTTTAAAACATTG
CTGAG-3′; reverse: 5′-CTCGATAATTGATGTCTCCT
AGCAT-3′], TAC-1 [forward: 5′-AAGCCTCAGCAGT
TCTTTGG-3′; reverse: 5′-TCTGGCCATGTCCATAAA
GA-3′], αCGRP [forward: 5′-AGCAGGAGGAAGAGC
AGGA-3′; reverse: 5′-CAGATTCCCACACCGCTTAG-
3′], B2M [forward: 5′-CCTGCAGAGTTAAGCATGCC-3′;
reverse: 5′-GATGCTTGATCACATGTCTCG-3′], HPRT
[forward: 5′-TCCTCCTCAGACCGCTTTT-3′; reverse: 5′-
CCTGGTTCATCATCGCTAATC-3′], GAPDH [forward:
5′-GGTCATCCCAGAGCTGAACG-3′; reverse: 5′-TTG
CTGTTGAAGTCGCAGGA-3′].
Results are expressed as copy numbers/μl of cDNA,
derived using the standard curve method [31]. Data were
then plotted against this standard curve using the Rotor-
gene 6000 series software and expressed as copies/μl of
cDNA. Results were normalized to the endogenous
housekeeping reference genes (B2M, HPRT and
GAPDH) using GeNorm (Version 3.4). The geometric
mean of the reference genes were calculated using GeN-
orm and results were normalized by dividing the copies/
μl of the target gene(s) of interest by a normalization
factor derived by GeNorm [32]. All experiments were
performed in accordance with MIQE guidelines [31].
Pharmacological treatment protocols
To assess the involvement of TRPA1 activation, the se-
lective TRPA1 antagonist HC-030031 (100 mg/kg; Tocris
Bioscience, Bristol, UK) or vehicle (10 % DMSO in sa-
line; n = 7) was administered intraperitoneally (i.p.) to
CD1 mice 30 min prior to cold exposure [30]. The con-
tribution of CGRP to blood flow was analysed by pre-
treatment with the CGRP antagonist CGRP8–37
(400 nmol/kg; Tocris Bioscience), administered intraven-
ously (i.v.) 15 min prior to recordings [33]. The partici-
pation of SP was evaluated by systemic administration of
neurokinin 1 (NK1) receptor antagonist SR140333
(480 nmol/kg; i.v.; Sigma-Aldrich) 15 min prior to blood
flow measurements [33]. The vehicle (2 % DMSO in sa-
line) was the same for both CGRP8–37 and SR140333.
Statistical analysis
Results are expressed as mean ± SEM from n number of
animals. Statistical analyses were performed by two-way
analysis of variance (ANOVA) or repeated measures
two-way ANOVA, as appropriate, followed by Bonferro-
ni’s adjustment for multiple comparisons. p values < 0.05
were considered significant.
Results
Cold exposure causes bilateral pain sensitivity in knee
joints of mice with CFA-induced mono-arthritis, in a
TRPA1-dependent manner
The effect of environmental cold on the pain threshold
of arthritic mice was evaluated through a range of noci-
ceptive parameters, namely the measurement of primary
and secondary mechanical hyperalgesia, thermal hyper-
algesia and weight-bearing distribution (Fig. 1). No dif-
ferences in baseline measurements were observed
between the groups. Two weeks after i.art. CFA injec-
tion, unilateral secondary mechanical hyperalgesia and
bilateral secondary thermal hyperalgesia were observed
both in mice maintained at RT and mice exposed to cold
(Fig. 1a and b), thus cold exposure had no effect on sec-
ondary measures of pain.
The incapacitance test was used to evaluate static
weight bearing in unrestrained mice, thus allowing for
quantification of pain-related guarding behaviour. At
2 weeks post-injection, mice were placing significantly
less weight through the ipsilateral CFA-treated hindlimb
compared to baseline. The effect was observed both in
mice maintained at RT and mice exposed to cold
(Fig. 1c).
A pressure application measurement device was
used to directly test primary mechanical hyperalgesic
thresholds of the knee joint. With this technique,
mice exposed to 1 h of cold (10 °C) exhibited signifi-
cant decreases in withdrawal thresholds in both ipsi-
lateral and contralateral joints (Fig. 2a), suggesting
that cold exposure had increased pain sensitivity in
both knee joints. Interestingly, mice maintained at RT
did not exhibit a decrease in withdrawal threshold
from baseline in the CFA-treated joint, but did show
a significant decrease from baseline in the contralat-
eral saline-treated joint (Fig. 2a). Different time
courses between ipsilateral and contralateral pain have
often been reported [16, 34, 35]. Thus, in our study,
the hyperalgesia observed in the CFA-treated knee
joint of animals exposed to RT may have resolved
faster than the contralateral hyperalgesia. This was
tested by examining the knee withdrawal thresholds
1 week post-CFA and -saline treatment. At this time
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point, mice maintained at RT had a significant de-
crease in threshold in the CFA-treated joint but not
in the saline-treated joint (Fig. 2b). Cold-exposed
mice had no differences in thresholds in either joint
(Fig. 2b), suggesting that at this early time point in
the progression of arthritis, cold may have an anal-
gesic effect.
We investigated the role of TRPA1 in the cold-
induced bilateral hyperalgesia at 2 weeks post-CFA
injection. Vehicle-treated CD1 mice exhibited significant
reductions in ipsilateral and contralateral knee with-
drawal thresholds 2 weeks after i.art. CFA and 1 h
exposure to cold (Fig. 2c), indicative of contralateral as
well as ipsilateral hyperalgesia. However, pretreatment
with the TRPA1 antagonist, HC-030031, prevented any
significant decreases in knee withdrawal thresholds
2 weeks after i.art CFA in cold-exposed animals (Fig. 2c).
HC-030031 also blocked the significant decrease in
weight bearing through the CFA-treated hindlimb at the
same time point (Fig. 2e). TRPA1 KO mice also did not
exhibit any changes in knee withdrawal threshold
(Fig. 2d). Surprisingly, TRPA1 WT mice did not show
significant changes in their knee withdrawal thresholds
(Fig. 2d), however WT mice did place significantly less
weight through the CFA-treated hindlimb at 2 weeks
than at baseline (Fig. 2f ). TRPA1 KO mice did not show
any significant changes in knee withdrawal thresholds
(Fig. 2d), and no changes in weight bearing were
observed (Fig. 2f ).
Knee joint blood flow differs between RT and
cold-exposed mice
Experiments using the FLPI showed that CD1 mice
maintained at RT exhibited reduced blood flow in their
CFA-treated joint (Fig. 3a and b). Cold exposure caused
a significant increase in flux in the synovial membrane
of ipsilateral CFA-treated joints compared to contralat-
eral saline-treated joints, naïve controls, and RT-
maintained CFA-treated joints (Fig. 3a and b). This
increase in flux is indicative of increased blood flow in
the synovial membrane after exposure to cold in the
CFA-treated joint. Experiments using the 99mTc clear-
ance technique showed that in RT-maintained mice, the
CFA-treated joint cleared 99mTc significantly slower over
the whole time course than the control saline-treated
joint (Fig. 3c shows percentage clearance after 5 min, at
which point naïve mice exhibit approximately 50 %
clearance). This difference in clearance disappeared
when mice were exposed to cold for 1 h (Fig. 3c).
TRPA1 mediates the cold-induced increase in synovial
blood flow in arthritic mice
We investigated the role of TRPA1 in mediating the dif-
ferences in blood flow caused by cold exposure in
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Fig. 1 Nociceptive thresholds and weight-bearing distribution in mice with CFA-induced mono-arthritis maintained either at RT or exposed to
cold (10 °C) for 1 h prior to measurements. a Secondary thermal hyperalgesia (using Hargreaves test). b Secondary mechanical hyperalgesia (using
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Fernandes et al. Arthritis Research & Therapy  (2016) 18:7 Page 5 of 12
animals with 2-week mono-arthritis. Figure 4a shows
that pretreatment with the selective TRPA1 antagonist
HC-030031 (100 mg/kg; i.p.) before the 1 h cold expos-
ure had no effect on 99mTc clearance. However, HC-
030031 blocked the increase in synovial blood flow
observed using FLPI after cold exposure (Fig. 4b).
TRPA1 WT mice had increased synovial blood flow in
their CFA-treated joint compared to saline-treated joint,
though this did not reach significance (Fig. 4c).
Following cold exposure, TRPA1 KO mice exhibited sig-
nificantly reduced blood flow in their CFA-treated joints
compared to their WT counterparts (Fig. 4c).
CGRP and SP are involved in the cold-induced increase in
synovial blood flow in arthritic mice
We next investigated the contribution of neuropep-
tides to the cold-induced changes in knee joint blood
flow in animals with 2-week mono-arthritis caused by
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Freund’s adjuvant, KO knockout, RT room temperature, TRPA1 transient receptor potential ankyrin 1, WT wild-type
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CFA. Both SP and CGRP are known to mediate in-
flammation and pain sensation in arthritic patients
and animal models of arthritis [36–39], and to be re-
leased from sensory neurons following activation of
TRPA1 receptors [40, 41]. Correspondingly, systemic
treatment with either the selective NK1 antagonist
SR140333 (480 nmol/kg; i.v.; 15 min) or the selective
CGRP antagonist CGRP8–37 (400 nmol/kg; i.v.;
15 min) prevented the increase in blood flow after
cold exposure (Fig. 4c).
Cold exposure alters TRPA1, TAC-1 and αCGRP mRNA
expression in knee joint tissues following CFA injection
Table 1 shows TRPA1 mRNA expression in DRG, patel-
lar cartilage and synovial membrane samples obtained
from the contralateral (saline-injected) and ipsilateral
(CFA-injected) sides 2 weeks after mono-arthritis induc-
tion. No significant differences in TRPA1 mRNA expres-
sion were found between contralateral and ipsilateral
sides in any samples obtained from RT-exposed animals
(Table 1). Cold exposure did not affect TRPA1 mRNA
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Fig. 3 Effect of cold exposure on knee joint blood flow in animals with CFA-induced mono-arthritis. Mono-arthritis was induced in animals by injection
of CFA (ipsilateral joint) and saline (contralateral joint). a FLPI images of blood flow in the recorded regions of interest from the synovial membrane in
naïve and arthritic animals following 1 h exposure to RT or cold (10 °C) 2 weeks after CFA injection. b Average blood flow measured using FLPI in joints
of naïve and arthritic animals at RT or exposed to cold, n = 7–8, *p < 0.05 compared to cold-exposed CFA-treated joint, #p < 0.05 compared to cold-
exposed naïve and saline-treated joints. c Percentage clearance of i.art. 99mTechnetium in the knee joint after 5 min in arthritic animals at RT or exposed
to cold, n = 7, *p < 0.05 compared with saline-treated counterparts. CFA complete Freund’s adjuvant, FLPI full-field laser perfusion imager, RT
room temperature
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A B
C D
Fig. 4 Participation of TRPA1, SP and CGRP in cold-induced increases in blood flow in arthritic animals. a Percentage clearance of i.art. 99mTechnetium
in the knee joint after 5 min in arthritic animals pretreated with selective TRPA1 antagonist, HC-030031 (100 mg/kg; i.p.), and exposed to cold (10 °C)
for 1 h, n = 6. b Knee joint blood flow recorded using FLPI from arthritic animals pretreated with selective TRPA1 antagonist, HC-030031 (100 mg/kg;
i.p.; 1 h), and exposed to cold (10 °C) for 1 h, n = 6–7, *p < 0.05 compared to vehicle-treated contralateral joint. c Knee joint blood flow recorded using
FLPI from arthritic WT and TRPA1 KO mice exposed to cold (10 °C) for 1 h, n = 6–7, #p < 0.05 compared to WT CFA joint. d Knee joint blood flow
recorded using FLPI in arthritic animals pretreated systemically with the selective NK1 antagonist SR140333 (480 mg/kg; i.v.; 15 min, n = 7) or the CGRP
antagonist CGRP8–37 (400 mg/kg; i.v.; 15 min, n = 7), and exposed to cold (10 °C) for 1 h. For the vehicle-treated group, n = 13,
*p < 0.05 compared to
vehicle-treated ipsilateral joint. CFA complete Freund’s adjuvant, CGRP calcitonin gene-related peptide, FLPI full-field laser perfusion imager, KO knock-
out, NK1 neurokinin 1, SP substance P, TRPA1 transient receptor potential ankyrin 1, WT wild-type
Table 1 mRNA expression in arthritic mice exposed to cold
Gene Tissue RT 10 °C
Saline CFA Saline CFA
TRPA1 DRG 862.76 ± 62.84 1116.79 ± 109.20 1005.35 ± 98.58 879.87 ± 63.95
TRPA1 Synovial membrane 24.17 ± 5.48 20.09 ± 5.41 31.98 ± 6.98 7.69 ± 0.98*
TRPA1 Patellar cartilage 41.20 ± 8.21 48.94 ± 10.15 45.56 ± 8.14 115.00 ± 42.37*#
TAC-1 DRG 8939.63 ± 1547.03 10197.42 ± 911.50 11325.64 ± 1143.52 7620.78 ± 1708.66
TAC-1 Synovial membrane 346.28 ± 70.11 132.70 ± 16.78* 362.31 ± 72.70 249.36 ± 99.34
TAC-1 Patellar cartilage 145.37 ± 42.49 86.91 ± 25.93 89.69 ± 24.76 214.74 ± 71.01
CGRP DRG 309931.4 ± 38430.2 370243.6 ± 45187.4 391659.9 ± 35192.5 252244.4 ± 52594.3
CGRP Synovial membrane 68.73 ± 15.55 48.38 ± 18.91 57.44 ± 6.89 24.98 ± 1.42
CGRP Patellar cartilage 43.38 ± 8.47 32.64 ± 9.02 33.98 ± 7.48 120.63 ± 46.56*#
TRPA1, TAC-1 and CGRP mRNA expression in DRG, synovial membrane, and patellar cartilage samples obtained from RT-and cold-exposed mice with 2-week CFA-
induced monoarthritis. Data are represented as copy numbers per μl of pure cDNA normalized by comparison to B2M, HPRT and GAPDH in contralateral (saline-
injected) and ipsilateral (CFA-injected) sides, n = 4–17, *p < 0.05, relative to saline-treated counterparts, #p < 0.05 relative to RT-exposed CFA-treated counterparts
RT room temperature, CFA complete Freund’s adjuvant, DRG dorsal root ganglia
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expression in DRG samples collected from either the
contralateral or the ipsilateral sides (Table 1). Interest-
ingly, cold exposure caused a significant downregulation
of TRPA1 mRNA in synovial membrane samples, whilst
a marked upregulation of TRPA1 mRNA was evident in
patellar cartilage samples collected from the ipsilateral
CFA-injected side (Table 1).
DRG mRNA expression levels of both αCGRP and
TAC-1 were similar between ipsilateral and contralateral
sides, irrespective of temperature (Table 1). There was a
significant reduction in TAC-1 expression in ipsilateral
CFA-treated synovial membrane samples from mice
maintained at RT. This reduction was lost in mice ex-
posed to cold (Table 1). Similar to TRPA1 expression
changes, αCGRP expression levels were upregulated in
ipsilateral CFA-treated patellar cartilage samples from
cold-exposed mice (Table 1).
Discussion
It is not known by what mechanism environmental cold
affects arthritis sufferers, though it is often reported as an
exacerbating factor for their condition. In this study, we
have used the CFA-induced mono-arthritis model with
exposure to cold (10 °C for 1 h), to investigate the effect of
acute environmental cold exposure on symptoms. We
show for the first time that after this acute exposure, bilat-
eral pain sensitivity occurs in the knee joints of cold-
exposed arthritic mice 2 weeks after induction of arthritis,
and that this is dependent on the cold sensor, TRPA1. Im-
portantly, we also reveal that increased blood flow is seen
in the CFA-treated knee joint after cold exposure. This is
also dependent on TRPA1, and involves the vasodilatory
neuropeptides, SP and CGRP.
We used a range of behavioural pain measurements in
our model. Secondary mechanical hyperalgesia was ob-
served after induction of CFA-induced mono-arthritis,
and was similar in both RT- and cold-exposed animals,
in keeping with previously published reports [16, 34]. Bi-
lateral thermal hyperalgesia was detected 2 weeks after
unilateral CFA injection, irrespective of temperature.
Contralateral effects during arthritis are commonly seen
both in animal models and humans [35, 42, 43] so this
was not a surprising result. Interestingly, using the pres-
sure application measurement technique to record pri-
mary mechanical hyperalgesia of the knee joint, we have
shown that mice maintained at RT had a significant de-
crease in threshold only in their contralateral saline-
treated joint and not in the ipsilateral CFA-treated joint
2 weeks after arthritis induction. Mechanisms underlying
ipsilateral and contralateral pain differ [27, 44], with the
latter thought to arise from central neurogenic mecha-
nisms [42, 45]. After induction of unilateral arthritis,
spontaneous antidromic action potentials have been re-
corded in contralateral sensory nerves [42, 45] and
contralateral inflammatory cytokine generation has been
observed [27]. One week after arthritis induction, mice
maintained at RT exhibited pain sensitivity in the CFA-
treated joint but not in the saline-treated joint (Fig. 2b).
Different time courses between ipsilateral and contralat-
eral pain have commonly been reported [16, 34, 35],
with resolution of ipsilateral pain occurring as the pain
on the contralateral side starts to manifest. We have pre-
viously shown in a model of TNF-α-induced mechanical
hypersensitivity that peripheral and central TRPA1 chan-
nels are important at different time points during the
development of ipsilateral and contralateral pain hyper-
sensitivity [16]. Importantly, the cold-exposed animals
exhibited hyperalgesia in both joints at 2 weeks, indica-
tive of cold-induced pain exacerbation.
We have previously demonstrated a role for TRPA1 in
the secondary mechanical hyperalgesia associated with
CFA-induced mono-arthritis [16], but until now no
study has assessed a role for TRPA1 in arthritic pain ex-
acerbation caused by environmental cold. Though there
is still discussion over whether and how TRPA1 can act
as a cold sensor for nociceptive responses in vivo [14],
there is much evidence linking TRPA1 to cold hypersen-
sitivity arising during inflammatory or neuropathic con-
ditions [8–10, 46]. We provide evidence that the
bilateral pain in arthritic animals exposed to cold is
TRPA1-dependent, as no significant hyperalgesia, when
measured with the pressure application measurement
device, was observed in both contralateral and ipsilateral
knee joints of mice treated with HC-030031 (Fig. 2c).
Surprisingly, TRPA1 WT mice did not show any thresh-
old differences between saline- and CFA-treated joints.
The TRPA1 genetically modified mice were generated
on a mixed genetic background containing both C57BL/
6 J and B6129PF2/J strains. Different mouse strains are
known to have differing nociceptive sensitivities [16, 47]
and several groups have reported issues with detecting
pain differences specifically in C57BL/6 mice [48, 49].
The variability in pain thresholds was greater in TRPA1
WT mice than KO mice 2 weeks after arthritis induc-
tion, and may be indicative of increased stress from the
handling and restraint necessary for pressure application
measurement. Despite the problems with the TRPA1
WT mice, data using the TRPA1 antagonist suggests
TRPA1 does play a role in the bilateral pain observed
after cold exposure. It is possible that TRPA1 is not
directly activated by cold in this study. Our studies in
skin suggest that TRPA1 very quickly senses noxious
cold [30], however, here we have a longer time course
which may facilitate lipid metabolism. It is well estab-
lished that cold exposure activates the sympathetic ner-
vous system resulting in liberation of free fatty acids
(FFA) and glycerol, from triglyceride hydrolysis in adi-
pose tissue, which are then released in the circulation
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and mobilized for energy [50]. However, we are not
aware of possible interactions between FFA and/or gly-
cerol with TRPA1, although, we have previously shown
an interaction with TRPA1 and the sympathetic nervous
system’s principal neurotransmitter, noradrenaline [30].
Therefore, it is likely that the results observed in this
study are upstream of lipid metabolism.
Vascular remodelling in the joint is a common
feature of arthritis, with the growth of blood vessels
from the subchondral bone into articular cartilage
[51]. Sensory nerve growth occurs together with the
angiogenesis, linking vascular effects to the develop-
ment of joint pain [39, 51, 52]. We used two different
techniques to examine blood flow in the knee joints
of mono-arthritic animals maintained at RT or ex-
posed to cold. FLPI allows real-time imaging of blood
flow specifically in the synovial membrane of the knee
joint, whereas clearance of i.art. injection of 99mTech-
netium is a measure of total blood flow in the entire
joint. Both techniques showed a reduction in blood
flow in CFA-treated joints compared to contralateral
saline-treated joints in animals maintained at RT, in
keeping with previous reports [21–23]. This is also
consistent with clinical observations of low microcir-
culatory flow in arthritic joints of patients with
rheumatoid arthritis, and is thought to be due to
increased microvascular resistance, as a result of
inflammation-induced dysfunction [20].
The primary objective of this study was to investi-
gate the effects of environmental cold on arthritis and
its associated mechanisms. In contrast to animals
maintained at RT, the CFA-treated joint of cold-
exposed animals did not exhibit reduced blood flow
compared to the saline-treated joint as shown using
the FLPI and 99mTechnetium clearance techniques.
Indeed, using FLPI, we recorded increased blood flow
in the CFA-treated joint compared to saline-treated
joint in cold-exposed CD1 mice. FLPI specifically de-
tects changes in blood flow in the synovial membrane
by illuminating the region with a laser and recording
speckle patterns produced by moving red blood cells,
thus generating flux values correlating to real-time
blood flow [29]. Therefore, this is a more sensitive
method of quantifying blood flow than 99mTechne-
tium clearance, which measures the rate of clearance
of 99mTechnetium from the intra-articular cavity into
the blood stream, and can be affected by various
factors [53]. Indeed, no changes in clearance rates
were observed after pretreatment with HC-030031 in
cold-exposed animals, however with FLPI, pretreat-
ment with HC-030031 prevented the increase in
blood flow seen after cold exposure in vehicle-treated
animals, suggesting the involvement of TRPA1. In
addition, TRPA1 KO mice have significantly reduced
blood flow in their CFA-treated joints compared to
their WT counterparts.
As yet, the functional importance of these changes in
blood flow after cold is not clear, so it is not known
whether these blood flow changes would be detrimental
or beneficial to the arthritic joint. However, as well as al-
tering blood flow, we have shown that TRPA1 blockade
reduces joint pain, and this would be a positive effect.
We have previously shown that activation of TRPA1
causes vasodilatation that is neuropeptide-dependent
[19]. Thus, we examined a role for SP and CGRP in the
cold-induced increase in blood flow. Systemic adminis-
tration of both the SP NK1 receptor antagonist,
SR140333, and the CGRP antagonist, CGRP8–37, pre-
vented the increase in blood flow observed in CFA-
treated joints after cold exposure. However, the antago-
nists also decreased blood flow in the contralateral
saline-treated joints, suggesting that SP and CGRP are
involved in general blood flow changes after cold, inde-
pendently of inflammation.
We examined mRNA expression levels of TRPA1,
TAC-1 and CGRP from joint tissues in mice maintained
at RT or exposed to cold, 2 weeks after arthritis induc-
tion, in order to detect the start of any potential changes
caused by acute cold exposure. A recent study has
shown that expression of the growth factor, vascular
endothelial growth factor (VEGF), and the inflammatory
mediator, interleukin-1 (IL-1), are increased in cartilage
cells from rats with CFA-induced arthritis after exposure
to low temperatures [54]. TRPA1, TAC-1 and CGRP are
all highly expressed in DRGs, and we observed no sig-
nificant differences in their expression under any of the
treatment conditions. The only gene altered by CFA
treatment in RT-exposed animals was TAC-1, which was
significantly reduced in the synovial membrane of the
ipsilateral joint. This is perhaps surprising, given that
SP-positive nerve fibres are present in the synovium, and
increased sensory neuronal growth is known to occur in
arthritic joints [39]. However, other groups have re-
ported a reduction in SP-containing synovial nerves dur-
ing inflammatory arthritis, suggesting that these nerves
may be destroyed by proteolytic enzymes released from
inflammatory cells during the course of the disease [55].
TRPA1 has been suggested to be expressed in non-
neuronal cells, including vascular cells [11] and synovio-
cytes [56], although lack of a selective anti-murine
TRPA1 antibody has limited studies of protein expres-
sion. We found low levels of TRPA1 mRNA expression
in the patellar cartilage and synovial membrane in all
samples, supporting the concept that TRPA1 gene ex-
pression is present in the joint. Whether this expression
arises from neuronal or non-neuronal sources, is unclear
at this stage. Cold exposure increases the expression of
TRPA1 and CGRP mRNA in the patellar cartilage of the
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CFA-treated joint but decreased levels of TRPA1 mRNA
are observed after cold in the synovial membrane from
the CFA-treated joint. Vascular remodeling leads to de-
struction of the synovial lining, and is associated with
neuronal growth into the cartilage in arthritic joints
[51]. However, it would be surprising if structural
changes could account for differences between RT-
exposed control joints and joints exposed to cold for just
1 hour. Although we are presently unable to account for
the differences in gene expression observed in this study,
it is possible that these changes have a direct impact on
blood flow and pain sensitivity under cold exposure. In-
deed, it has been suggested that cold exposure leads to
increased expression of inflammatory mediators in arth-
ritic joints, such as VEGF, a key angiogenic factor, [54].
Hence expression of key inflammatory and vascular fac-
tors may represent the initial step towards altered joint
pathology, leading to an exacerbation of arthritic symp-
toms following prolonged exposure to cold. Interest-
ingly, a recent study detected increased levels of TRPA1
expression in the skin of subjects with higher pain
thresholds, and this expression was regulated through
differential methylation of the TRPA1 promoter [57].
Thus, TRPA1 may contribute to pain sensitivity through
tight regulation of its expression.
Conclusions
This study provides the first evidence that environmen-
tal cold exposure alters pain sensitivity and blood flow
in a murine model of arthritis. Our findings are in keep-
ing with the concept that pharmacological manipulation
of peripheral TRPA1 channels may attenuate changes in
blood flow and hyperalgesia associated with arthritis,
particularly in cold conditions.
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